Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2192-2195, September 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtis, G. L.
Right arrow Articles by Ryan, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtis, G. L.
Right arrow Articles by Ryan, W. L.

Enhancement of 7,12-Dimethylbenzanthracene Skin Carcinogenesis by Adenosine 3',5'-Cyclic Monophosphate1

Gary L. Curtis2, Frej Stenback and Wayne L. Ryan

The Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105

Adenosine 3',5'-cyclic monophosphate was injected i.p. into strain A mice receiving the chemical carcinogen 7,12-dimethylbenzanthracene topically on the interscapular area of the skin. Adenosine 3',5'-cyclic monophosphate increased the incidence of skin papillomas and squamous cell carcinomas in the 7,12-dimethylbenzanthracene-treated mice whereas 5'-adenosine monophosphate, the immediate metabolite of adenosine 3',5'-cyclic monophosphate, had no effect on the incidence of tumors in 7,12-dimethylbenzanthracene-treated mice.

1 This work was supported by American Cancer Society Grant BC-48A and National Cancer Institute Contract PH43-68-959.

2 Recipient of USPHS Postdoctoral Fellowship CA05220.

Received 2/19/74. Accepted 5/10/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.